Order Article Reprints

Savic LJ, Chen E, Nezami N, Murali N, Hamm CA, Wang C, Lin M, Schlachter T, Hong K, Georgiades C, et al. Conventional vs. Drug-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma—A Propensity Score Weighted Comparison of Efficacy and Safety. Cancers. 2022; 14(23):5847. https://doi.org/10.3390/cancers14235847

Savic, Lynn Jeanette, Evan Chen, Nariman Nezami, Nikitha Murali, Charlie Alexander Hamm, Clinton Wang, MingDe Lin, Todd Schlachter, Kelvin Hong, Christos Georgiades, and et al. 2022. "Conventional vs. Drug-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma—A Propensity Score Weighted Comparison of Efficacy and Safety" Cancers 14, no. 23: 5847. https://doi.org/10.3390/cancers14235847

Savic, L. J., Chen, E., Nezami, N., Murali, N., Hamm, C. A., Wang, C., Lin, M., Schlachter, T., Hong, K., Georgiades, C., Chapiro, J., & Laage Gaupp, F. M. (2022). Conventional vs. Drug-Eluting Beads Transarterial Chemoembolization for Unresectable Hepatocellular Carcinoma—A Propensity Score Weighted Comparison of Efficacy and Safety. Cancers, 14(23), 5847. https://doi.org/10.3390/cancers14235847